1. Comorbidity between epilepsy and depression: Role of hippocampal interleukin-1β
- Author
-
Andrey M. Mazarati, Eduardo Pineda, Don Shin, Delia Tio, Anna N. Taylor, and Raman Sankar
- Subjects
Temporal lobe epilepsy ,Depression ,Comorbidity ,Brain inflammation ,Interleukin-1β ,Hippocampus ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Depression is a frequent comorbidity of temporal lobe epilepsy (TLE); however, its mechanisms remain poorly understood and effective therapies are lacking. Augmentation of hippocampal interleukin-1β (IL-1β) signaling may be a mechanistic factor of both TLE and clinical depression. We examined whether pharmacological blockade of hippocampal interleukin-1 receptor exerts antidepressant effects in an animal model of comorbidity between TLE and depression, which developed in Wistar rats following pilocarpine status epilepticus (SE). In post-SE animals, depression-like state was characterized by behavioral equivalents of anhedonia and despair; dysregulation of the hypothalamo–pituitary–adrenocortical axis; compromised raphe–hippocampal serotonergic transmission. Two-week long bilateral intrahippocampal infusion of human recombinant Interleukin-1 receptor antagonist (IL-1ra) improved all of the examined depressive impairments, without modifying spontaneous seizure frequency and without affecting normal parameters in naïve rats. These findings implicate hippocampal IL-1β in epilepsy-associated depression and provide a rationale for the introduction of IL-1β blockers in the treatment of depression in TLE.
- Published
- 2010
- Full Text
- View/download PDF